Company: PETVW
Filing Date: 2025-07-10
Form Type: 10-K
Source: 0001641172-25-018617
Chunk: 535

Company: PetVivo Holdings, Inc.
Filing Date: 2025-07-10
Form: 10-K
Item: Item 4
Chunk 535
---
,000.

From
January 2025 to March 2025, the Company issued 144,000 shares of common stock to service providers for consulting services valued at
$104,780.

From
January 2025 to March 2025, the Company issued 72,812 shares of common stock upon the vesting of restricted stock units.

In
March 2025, the Company issued 230,770 shares of common stock for an investment in Digital Landia valued at $150,000.

In
March 2025, the Company issued 225,000 shares of common stock to its executive officers for performance services valued at $156,250.

In
March 2025, the Company issued 68,628 shares of common stock to its executive officers for conversion of accrued bonuses valued at $35,000.

In
March 2025, the Company issued 150,072 shares of common stock to employees and Board Directors for stock option buyout program valued
at $72,808.

In
March 2025, the Company issued 2,317 shares of common stock related to a cashless warrant exercise.

26

All
of these transactions described above were exempt from registration in reliance on Section 4(a)(2) of the Securities Act of 1933, as
amended, as a transaction by an issuer not involving a public offering. The purchasers of securities in each of these transactions represented
their intention to acquire securities for investment only and not with a view to offer or sell, in connection with any distribution of
the securities, and appropriate legends were affixed to the share certificates and instruments issued in such transactions.

Purchases
of Equity Securities by the Registrant and Affiliated Purchasers

None.

Securities
Authorized for Issuance

The
following table sets forth securities authorized for issuance under any equity compensation plan approved by our stockholders as well
as any equity compensation plans not approved by our stockholders as of March 31, 2025.

    Equity Compensation Plan Information

    Plan category 
    Number of securities to be issued upon exercise of outstanding options, warrants, and rights  
    Weighted average exercise price of outstanding options, warrants, and rights  
    Number of Securities remaining available for future issuance under  equity compensation plans (excluding securities  reflect in table)

    Plans approved by shareholders(1) 
     
     1,140,933  
    $2.58  
    822,605